发明名称 Allograft tolerance induction
摘要 A method inducing chimerism and allograft tolerance by co-infusion of stem/progenitor-like cells and donor cells, wherein the donor cells can be bone marrow cells. The method also comprises the conditioning comprising depletion of CD4+ and CD8+ T-cells and administration of low doses of anti-neoplastic drugs. The inventive method comprises an aspect wherein allograft tolerance is induced without systemically suppressing the immune system.
申请公布号 US9457052(B2) 申请公布日期 2016.10.04
申请号 US201414210701 申请日期 2014.03.14
申请人 The United States of America as Represented by the Secretary of the Navy 发明人 Davis Thomas A.;Anam Khairul;Elster Eric A.;Tadaki Douglas K.
分类号 A61K35/28;A61K45/06;A61K31/255;A61K39/00;C12N5/073;C12N5/0775;A61K35/12 主分类号 A61K35/28
代理机构 代理人 Churilla Albert M.;Yang Ning;Tso Diane P.
主权项 1. A transplantation method comprising inducing allograft tolerance and chimerism by: a) administering, intravenously, subcutaneously, or intradermally, to a host one or more doses of human stem/progenitor-like cells, wherein said human stem/progenitor-like cells are adipose-derived stem cells isolated from fresh human subcutaneous adipose lipoaspirate; b) administering, intravenously, subcutaneously or intradermally, to a host, donor cells, wherein said donor cells are allogeneic to the host, and wherein said donor cells are unprocessed bone marrow, or low density bone marrow cells, wherein said donor cells are administered up to ten (10) days after administration of said human stem/progenitor-like cells in step (a); c) transplanting tissue, allogenic to the host but autologous to the donor cells up to ten (10) days before or after administration of said human stem/progenitor cells; and d) depleting of CD4+ and CD8+ cell of the host; and e) administering a nonmyeloablative anti-neoplastic agent.
地址 Washington DC US